ILKI efficacy in 3D breast tumor models with different TME components highlights the importance of dynamic cell‐ECM in driving integrin signaling, where physical cues from the ECM influence integrin activation and the signaling cascades involving ILK, leading to ILK expression and activity patterns that are more representative of the in vivo tumors. The gene discussed is ILK; the disease is breast neoplasm.